Clinical Trial Update: A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the effects of PF-05175157 in healthy volunteers has completed. The study lists Diabetes Mellitus, Type 2 as the condition context.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-05175157

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED